Menu Back to 6th-Latin-American-Regulatory-Conference-LARC-2014

Program Committee

  • Justina  Molzon, JD, MS
    Justina Molzon, JD, MS
    FDA (Retired), United States
  • Mike  Ward
    Mike Ward Coordinator, Regulatory Systems Strengthening, EMP
    World Health Organization (WHO), Switzerland
  • Sergio  Guerrero, MD
    Sergio Guerrero, MD Clinical Research Professional
    Independent Consultant, United States
  • Ines  Bignone, MD
    Ines Bignone, MD Department of Medicine Evaluation
    ANMAT, Argentina
  • Guisela  Zurich Reszczynski
    Guisela Zurich Reszczynski Head
    ANAMED/ISPCH, Chile
  • Laura  Gomes Castanheira
    Laura Gomes Castanheira Head of Regulatory Affairs
    Hemobrás- Empresa Brasileira de Hemoderivados e Biotecnologia, Brazil
  • Beatriz  Luna
    Beatriz Luna Director, Medicines Department
    Ministry of Public Health, Uruguay
  • Cesar  Masache, MD
    Cesar Masache, MD Head, National System on Pharmacotherapy & Pharmacovigilance
    Ministry of Public Health, Ecuador
  • Gerardo  Méndez Ciancaglini, MD
    Gerardo Méndez Ciancaglini, MD Professor
    Universidad De Buenos Aires, Argentina
  • Lily  Gordillo, MSc
    Lily Gordillo, MSc Director, Pharmacovigilance
    Ministry of Public Health, Guatemala
  • João  Massud, MD
    João Massud, MD President
    Brazilian Society of Pharmaceutical Medicine (SBMF), Brazil
  • Jenny  Paredes, MD
    Jenny Paredes, MD Latin American Operations Manager
    PRA Health Sciences, Mexico
  • Maria  Guazzaroni Jacobs, PhD
    Maria Guazzaroni Jacobs, PhD Director, Quality and Regulatory Policy (QRP)
    Pfizer Inc, United States
  • Thomas  Kirchlechner, PhD
    Thomas Kirchlechner, PhD Head, Regulatory Emerging Markets
    Sandoz Biopharmaceuticals Development (Novartis), Austria
  • Rivelino  Flores, MSc
    Rivelino Flores, MSc Director, Regulatory Affairs & Innovation
    CANIFARMA, Mexico
  • Ian  Rentsch, JD
    Ian Rentsch, JD Senior Director, Business Development and Head of Latin American Sales
    Quintiles, Argentina
Load More